[Form 4] UPEXI, INC. Insider Trading Activity

Rhea-AI Filing Summary

Upexi, Inc. (UPXI) reported insider share purchases by director Gene Salkind. On 11/17/2025, he bought a total of 200,000 shares of common stock in open-market transactions.

He acquired 100,000 shares directly at $2.65 per share, bringing his directly owned stake to 569,470 shares. He also acquired another 100,000 shares at $2.81 per share through the Marital Trust GST subject U/W/O Leopold Salkind, where he serves as trustee, resulting in 168,750 shares of indirect beneficial ownership.

The filing classifies him as a director of Upexi and treats the trust-held shares as indirect ownership because they are controlled in his role as trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salkind Gene

(Last) (First) (Middle)

3030 NORTH ROCKY POINT DRIVE

SUITE 420

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UPEXI, INC. [ UPXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		P		100,000	A	$2.65	569,470	D
Common Stock	11/17/2025		P		100,000	A	$2.81	168,750	I(1)	Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind.

Remarks:

	/s/ Gene Salkind	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Upexi (UPXI) report in this Form 4?

The company reported that director Gene Salkind purchased a total of 200,000 shares of Upexi common stock in open-market transactions on 11/17/2025.

How many Upexi (UPXI) shares did Gene Salkind buy and at what prices?

Gene Salkind bought 100,000 shares at $2.65 per share directly and another 100,000 shares at $2.81 per share through a marital trust.

What is Gene Salkind27s role at Upexi (UPXI)?

The filing identifies Gene Salkind as a director of Upexi, Inc.

How many Upexi (UPXI) shares does Gene Salkind own after these trades?

After the reported transactions, he beneficially owns 569,470 shares directly and 168,750 shares indirectly through a marital trust where he is trustee.

What is the indirect ownership reported for Upexi (UPXI) in this filing?

The Form 4 explains that 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind, with Gene Salkind as trustee, and these are treated as his indirect ownership.

Is this Upexi (UPXI) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, specifically Gene Salkind.